Ensign Group Inc (ENSG) Stock Analysis
Verdict: AVOID
A high-premium valuation meets a devastating short report alleging fraud—technical breakdown and insider selling confirm a 'falling knife'.
Investment score: 38/100
Analysis as of
Is Ensign Group Inc stock worth reviewing? The TradeMates thesis
Avoid ENSG until the Hunterbrook allegations are addressed or the price stabilizes at a valuation closer to its hospital peers.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 20/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 15/100 (weight 10%)
Ensign Group Inc opportunities and risks
What speaks for ENSG
- Aggressive M&A Pipeline
What speaks against ENSG
- Regulatory and Legal Fraud Allegations
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ENSG | 24.9x | 1.7x | 18.2x | 13.9% | 6.9% | 4.4% |
| HCA | 12.1x | 1.0x | 8.2x | 34.9% | 8.9% | 9.9% |
| THC | 8.3x | 0.7x | 5.5x | 42.8% | 7.9% | 23.9% |
| EHC | 16.5x | 1.7x | 8.8x | 58.8% | 10.0% | 4.6% |
| UHS | 5.7x | 0.5x | 5.0x | 71.3% | 8.6% | 10.0% |
| PACS | 22.6x | 1.0x | 18.9x | 19.2% | 4.5% | 4.3% |
| Peer median | 12.1x | 1.0x | 8.2x | 42.8% | 8.6% | 9.9% |
Frequently asked questions about Ensign Group Inc (ENSG)
Is ENSG stock a good investment?
The TradeMates model rates Ensign Group Inc as AVOID with an investment score of 38/100. Avoid ENSG until the Hunterbrook allegations are addressed or the price stabilizes at a valuation closer to its hospital peers. This is algorithmic model output, not personal investment advice.
Is ENSG stock a buy?
The TradeMates model verdict for ENSG is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.